Variables | Total | Group without SI (n = 389) M ± SD/n (%) | Group with SI (n = 116) M ± SD/n (%) | t /χ2 | p | Effect size Cohen’s d/ Cramer’s V |
---|---|---|---|---|---|---|
Age | 50.34 ± 9.996 | 50.12 ± 9.762 | 51.27 ± 10.481 | -1.090 | 0.276 | -0.115 (Cohen’s d) |
18–45 | 168(33.5) | 128(33.2) | 39(33.6) | 3.650 | 0.161 | 0.085 |
46–64 | 294(58.6) | 231(60.0) | 63(54.3) | |||
≥65 | 40(8.0) | 26(6.8) | 14(12.1) | |||
Education | 4.555 | 0.103 | 0.097 | |||
Middle school and under | 254(51.9) | 191 (50.7) | 62(55.9) | |||
High and professional school | 139(28.4) | 104 (27.6) | 35(31.5) | |||
College and above | 96(19.6) | 82(21.8) | 14(12.6) | |||
ECOG | 6.411 | 0.041* | 0.113 | |||
0 | 189(37.4) | 150 (38.6) | 39(33.6) | |||
1 | 240(47.4) | 189(48.6) | 51(44.0) | |||
2 | 77(15.2) | 50(12.9) | 26(22.4) | |||
Weight loss | 0.339 | 0.561 | 0.026 | |||
Weight loss<5% | 386(76.3) | 295(75.8) | 91(78.4) | |||
Weight loss ≥ 5% | 120(23.7) | 94(24.2) | 25(21.6) | |||
Marital status | 0.079 | 0.779 | 0.045 | |||
Without partner | 32(6.3) | 27(6.9) | 5(4.3) | |||
Married | 474(93.7) | 362(93.1) | 111(95.7) | |||
Job situation | 1.042 | 0.307 | 0.048 | |||
Full time | 244 (48.2) | 193(49.6) | 51 (44.0) | |||
Part time and unemployed | 262(51.8) | 196(50.4) | 65 (56.0) | |||
Cancer stage | 7.811 | 0.005** | 0.124 | |||
Cancer in situ/local metastasis | 159(32.8) | 126(32.4) | 54(46.6) | |||
Remote metastasis | 326(67.2) | 263(67.6) | 62(53.4) | |||
Income (RMB/month) | 0.441 | 0.932 | 0.032 | |||
<3000 | 134(30.2) | 101(29.4) | 32(32.0) | |||
≥3000, <6000 | 137(30.9) | 107(31.2) | 30(30.0) | |||
≥6000, <10,000 | 83(18.7) | 66(19.2) | 17(17.0) | |||
≥10,000 | 90(20.3) | 69(20.1) | 21(21.0) | |||
Quantity of living persons | 0.112 | 0.739 | 0.015 | |||
3 and under | 290(59.8) | 220(59.3) | 69(61.1) | |||
4 and above | 195(40.2) | 151(40.7) | 44(38.9) | |||
Anti-cancer treatment now | 0.614 | 0.433 | 0.035 | |||
No | 91 (18.6) | 87(22.4) | 30(25.9) | |||
Yes | 389(79.6) | 302(77.6) | 86(74.1) | |||
Using opioid | 0.891 | 0.345 | 0.042 | |||
No | 476(94.1) | 368(94.6) | 107(92.2) | |||
Yes | 30(5.9) | 21(5.4) | 9(7.8) | |||
Using anti-vomiting drugs | 0.655 | 0.418 | 0.036 | |||
No | 445 (87.4) | 343(88.2) | 99(85.3) | |||
Yes | 64 (12.6) | 46(11.8) | 17(14.7) | |||
Using endocrine drugs | 1.000 | 0.317 | 0.045 | |||
No | 465(91.9) | 360(92.5) | 104(89.7) | |||
Yes | 41(8.1) | 29(7.5) | 12(10.3) |